However, previous studies have shown that long-term administration of insulin to people with T1DM can cause kidney damage via a number of signal pathways, including the protein kinase B-mechanistic target of rapamycin kinase C1 (Akt-mTORC1) pathway, which makes the spectrum of renal disease among these patients complex (37). The gene discussed is AKT1; the disease is kidney disorder.